Aa Aa Aa
  • Investor Information Overview

Corporate Profile
Sucampo Pharmaceuticals, Inc. is a publicly traded (NASDAQ: SCMP) global biopharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and are also considering o  More >>
Stock Quote
SCMP (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%)0.00 (0.00%)
Data as of 03/31/15 4:00 p.m. ET
Refresh quote
Recent NewsRSS   | More >>
03/26/15Sucampo Prices Public Offering of Common Stock by Selling StockholdersPrinter Friendly Version
03/25/15Sucampo Announces Proposed Public Offering by Selling StockholdersPrinter Friendly Version
03/09/15Sucampo to Return All Licenses for Unoprostone Isopropyl to R-Tech UenoPrinter Friendly Version
03/04/15Sucampo Reports Fourth Quarter and Full Year 2014 Financial Results and Corporate UpdatePrinter Friendly Version
Upcoming Events
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed.